S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

TransAlta (TA) Earnings Date, Estimates & Call Transcripts

C$8.89
+0.04 (+0.45%)
(As of 04/19/2024 08:52 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 3
Before Market Opens
Confirmed
Actual EPS
(Feb. 23)
-C$0.27 Missed By -C$0.45
Consensus EPS
(Feb. 23)
C$0.18
Skip Charts & View Estimated and Actual Earnings Data

TA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

TransAlta Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241C$0.14C$0.14C$0.14
Q2 20241C$0.06C$0.06C$0.06
Q3 20241C$0.35C$0.35C$0.35
Q4 20241C$0.14C$0.14C$0.14
FY 20244C$0.69C$0.69C$0.69

TA Earnings Date and Information

TransAlta last released its quarterly earnings data on February 23rd, 2024. The reported C($0.27) earnings per share for the quarter, missing the consensus estimate of C$0.18 by C$0.45. The company had revenue of C$624 million for the quarter. TransAlta has generated C$2.33 earnings per share over the last year (C$2.33 diluted earnings per share) and currently has a price-to-earnings ratio of 3.8. TransAlta has confirmed that its next quarterly earnings report will be published on Friday, May 3rd, 2024.

TransAlta Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/3/2024
Confirmed)
------- 
2/23/2024Q4 2023C$0.18C($0.27)C($0.45)C($0.27)-C$624.00 million
11/7/2023Q3 2023C$0.43C$1.19+C$0.76C$0.97-C$1.02 billion
8/4/2023Q2 2023C$0.04C$0.23+C$0.19C$0.23-C$625.00 million
5/5/2023Q1 2023C$0.39C$1.10+C$0.71C$1.10-C$1.09 billion
2/23/2023Q4 2022C$0.68C($0.61)C($1.29)C($0.61)-C$854.00 million
11/8/2022Q3 2022C$0.34C$0.23C($0.11)C$0.23-C$929.00 million
8/5/2022Q2 2022C$0.16C($0.30)C($0.46)C($0.30)-C$458.00 million
5/6/2022Q1 2022C$0.10C$0.57+C$0.47C$0.45-C$735.00 million
2/24/2022Q4 2021C$0.07C($0.19)C($0.26)C($0.09)-C$610.00 million
11/9/2021Q3 2021C$0.20C$0.44+C$0.24C$2.56-C$850.00 million
8/10/2021Q2 2021C$0.06C$0.08+C$0.02C$0.20-C$619.00 million
5/13/2021Q1 2021C$0.19C($0.03)C($0.22)C$0.05-C$642.00 million

TransAlta Earnings - Frequently Asked Questions

When is TransAlta's earnings date?

TransAlta has confirmed that its next quarterly earnings data will be published on Friday, May 3rd, 2024. Learn more on TA's earnings history.

Did TransAlta beat their earnings estimates last quarter?

In the previous quarter, TransAlta (TSE:TA) missed the analysts' consensus estimate of C$0.18 by C$0.45 with a reported earnings per share (EPS) of C($0.27). Learn more on analysts' earnings estimate vs. TA's actual earnings.

How much revenue does TransAlta generate each year?

TransAlta (TSE:TA) has a recorded annual revenue of C$3.36 billion.

How much profit does TransAlta generate each year?

TransAlta (TSE:TA) has a recorded net income of C$644 million. TA has generated C$2.33 earnings per share over the last four quarters.

What is TransAlta's price-to-earnings ratio?

TransAlta (TSE:TA) has a trailing price-to-earnings ratio of 3.82 and a forward price-to-earnings ratio of 18.91. The price/earnings-to-growth ratio is -0.07.


More Earnings Resources from MarketBeat

This page (TSE:TA) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners